These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 16143170)

  • 1. Pain in Parkinson's disease and multiple sclerosis: its relation to the medial and lateral pain systems.
    Scherder E; Wolters E; Polman C; Sergeant J; Swaab D
    Neurosci Biobehav Rev; 2005; 29(7):1047-56. PubMed ID: 16143170
    [TBL] [Abstract][Full Text] [Related]  

  • 2. fMRI investigation of disinhibition in cognitively impaired patients with multiple sclerosis.
    Smith AM; Walker LA; Freedman MS; DeMeulemeester C; Hogan MJ; Cameron I
    J Neurol Sci; 2009 Jun; 281(1-2):58-63. PubMed ID: 19344919
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cognitive dysfunction in non-demented Parkinson's disease patients: controlled and automatic behavior.
    Koerts J; Leenders KL; Brouwer WH
    Cortex; 2009 Sep; 45(8):922-9. PubMed ID: 19327762
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Amnestic mild cognitive impairment in Parkinson's disease: a brain perfusion SPECT study.
    Nobili F; Abbruzzese G; Morbelli S; Marchese R; Girtler N; Dessi B; Brugnolo A; Canepa C; Drosos GC; Sambuceti G; Rodriguez G
    Mov Disord; 2009 Feb; 24(3):414-21. PubMed ID: 19235928
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Chronic pain in dementia and in disorders with a high risk for congnitive impairment].
    Scherder EJ; Oosterman JM; Ooms ME; Ribbe MW; Swaab DF
    Tijdschr Gerontol Geriatr; 2005 Jul; 36(3):116-21. PubMed ID: 16078658
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cognitive decline correlates with neuropathological stage in Parkinson's disease.
    Braak H; Rüb U; Del Tredici K
    J Neurol Sci; 2006 Oct; 248(1-2):255-8. PubMed ID: 16814807
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cognitive impairment in incident, untreated Parkinson disease: the Norwegian ParkWest study.
    Aarsland D; Brønnick K; Larsen JP; Tysnes OB; Alves G;
    Neurology; 2009 Mar; 72(13):1121-6. PubMed ID: 19020293
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cognitive assessment and quantitative magnetic resonance metrics can help to identify benign multiple sclerosis.
    Amato MP; Portaccio E; Stromillo ML; Goretti B; Zipoli V; Siracusa G; Battaglini M; Giorgio A; Bartolozzi ML; Guidi L; Sorbi S; Federico A; De Stefano N
    Neurology; 2008 Aug; 71(9):632-8. PubMed ID: 18725589
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cognitive change in Parkinson disease.
    Galvin JE
    Alzheimer Dis Assoc Disord; 2006; 20(4):302-10. PubMed ID: 17132978
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anticholinesterasics in the treatment of cognitive impairment in multiple sclerosis.
    Porcel J; Montalban X
    J Neurol Sci; 2006 Jun; 245(1-2):177-81. PubMed ID: 16674980
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cognitive changes in Parkinson's disease patients with visual hallucinations.
    Ramirez-Ruiz B; Junque C; Marti MJ; Valldeoriola F; Tolosa E
    Dement Geriatr Cogn Disord; 2007; 23(5):281-8. PubMed ID: 17351320
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cognitive impairment and its relation with disease measures in mildly disabled patients with relapsing-remitting multiple sclerosis: baseline results from the Cognitive Impairment in Multiple Sclerosis (COGIMUS) study.
    Patti F; Amato MP; Trojano M; Bastianello S; Tola MR; Goretti B; Caniatti L; Di Monte E; Ferrazza P; Brescia Morra V; Lo Fermo S; Picconi O; Luccichenti G;
    Mult Scler; 2009 Jul; 15(7):779-88. PubMed ID: 19542262
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neuroimaging of nonmotor features of Parkinson's disease.
    Deblieck C; Wu AD
    Rev Neurol Dis; 2008; 5(3):125-33. PubMed ID: 18838952
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Are dopaminergic pathways involved in theory of mind? A study in Parkinson's disease.
    Péron J; Vicente S; Leray E; Drapier S; Drapier D; Cohen R; Biseul I; Rouaud T; Le Jeune F; Sauleau P; Vérin M
    Neuropsychologia; 2009 Jan; 47(2):406-14. PubMed ID: 18845171
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Parkinsonism and multiple sclerosis--is there association?
    Barun B; Brinar VV; Zadro I; Lusić I; Radović D; Habek M
    Clin Neurol Neurosurg; 2008 Nov; 110(9):958-61. PubMed ID: 18482794
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cognitive impairment in Parkinson's disease: tools for diagnosis and assessment.
    Kulisevsky J; Pagonabarraga J
    Mov Disord; 2009 Jun; 24(8):1103-10. PubMed ID: 19353727
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cognitive changes in early MS: a call for a common framework.
    Achiron A; Barak Y
    J Neurol Sci; 2006 Jun; 245(1-2):47-51. PubMed ID: 16635495
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Functional ability correlates with cognitive impairment in Parkinson's disease and Alzheimer's disease.
    Sabbagh MN; Lahti T; Connor DJ; Caviness JN; Shill H; Vedders L; Mahant P; Samanta J; Burns RS; Evidente VG; Driver-Dunckley E; Reisberg B; Bircea S; Adler CH
    Dement Geriatr Cogn Disord; 2007; 24(5):327-34. PubMed ID: 17851237
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multiple sclerosis-related cognitive changes: a review of cross-sectional and longitudinal studies.
    Amato MP; Zipoli V; Portaccio E
    J Neurol Sci; 2006 Jun; 245(1-2):41-6. PubMed ID: 16643953
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Behavioral responses and Fos activation following painful stimuli in a rodent model of Parkinson's disease.
    Tassorelli C; Armentero MT; Greco R; Fancellu R; Sandrini G; Nappi G; Blandini F
    Brain Res; 2007 Oct; 1176():53-61. PubMed ID: 17884026
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.